| Cat.No. | Name | Information |
|---|---|---|
| M2147 | Ilomastat | Ilomastat (GM6001; Galardin) is a broad spectrum matrix metalloprotease (MMP) inhibitor with Ki values of 0.4 nM, 0.5 nM, 27 nM, 3.7 nM, 0.1 nM, 0.2 nM, 3.6 nM, 13.4 nM and 0.36 nM for MMPs -1, -2, -3, -7, -8, -9, -12, -14 and -26, respectively. Ilomastat (GM6001; Galardin) reduces infarct volume following middle cerebral artery occlusion in an ischemic mouse model. |
| M4907 | Doxycycline Hyclate | Doxycycline is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. |
| M7413 | TMI 1 | TMI 1 is a adam 17 (TACE) and MMP inhibitor; orally bioavailable. |
| M9373 | T-5224 | T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects. |
| M4779 | Cordycepin | Cordycepin (3'-Deoxyadenosine) is a nucleoside derivative isolated from Cordyceps, inhibits IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts. |
| M52567 | Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2 | Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2 is a fluorogenic substrate for matrix metalloproteinase-1 (MMP-1), MMP-3, and MMP-26. |
| M52566 | Mca-PLGL-Dpa-AR-NH2 | Mca-PLGL-Dpa-AR-NH2 is a fluorescent peptide MMP substrate. |
| M52564 | MMP3 inhibitor 3 | MMP3 inhibitor 3 is an inhibitor of MMP3. |
| M52562 | Dnp-PYAYWMR | Dnp-PYAYWMR is a peptide substrate that selectively targets MMP3. |
| M52561 | GPLGIAGQ | GPLGIAGQ, a MMP2-cleavable polypeptide, is used as a stimulus-sensitive linker in both liposomal and micellar nanocarriers for MMP2-triggered tumor targeting. |
| M52560 | FFAGLDD | FFAGLDD is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release. |
| M50179 | ARO-MMP7 | ARO-MMP7 is a small interfering RNA (siRNA) that reduces matrix metalloproteinase 7 (MMP7) expression and can be used in studies related to idiopathic pulmonary fibrosis (IPF). |
| M49482 | Otaplimastat | Otaplimastat is a matrix metalloproteinase (MMP) inhibitor that competitively blocks NMDA receptor-mediated excitotoxicity. In addition, Otaplimastat has antioxidant activity and may be used in studies related to cerebral ischemic injury. |
| M42522 | TNO211 | TNO211 is a biological active peptide. |
| M42521 | NFF-3 | NFF-3, the peptide, is a selective MMP substrate. |
| M42520 | FN-439 TFA | FN-439 TFA is a selective collagenase-1 inhibitor. |
| M42519 | NFF-3 TFA | NFF-3 TFA, the peptide, is a selective MMP substrate. |
| M42518 | MMP-7-IN-2 | MMP-7-IN-2 is a selective MMP7 inhibitor, with an IC50 of 16 nM. |
| M42517 | ND-322 hydrochloride | ND-322 hydrochloride is a potent and selective water-soluble gelatinase inhibitor. |
| M42516 | MMP-13-IN-1 | MMP-13-IN-1 is a potent and selective inhibitor of MMP-13 with a IC50 value of 16 nM. |
| M42515 | MMP-9-IN-6 | MMP-9-IN-6 is a MMP-9 inhibitor with IC50 value of 50 μM, which has good anti-ulcer effect. |
| M42514 | RXP470.1 | RXP470.1 (RXP-470) is a potent, selective MMP-12 inhibitor with a Ki of 0.2 nM against human MMP-12. |
| M42513 | VPLSLYSG | VPLSLYSG is an octapeptide that can be degraded by matrix metalloproteinase-9 (MMP-9), MMP-1 and MMP-2. |
| M42512 | MMP13-IN-4 | MMP13-IN-4 is a potent and selective inhibitor of MMP-13 (IC50=14.6 μM), involved in osteoarthritis (OA). |
| M42511 | MMP13-IN-5 | MMP13-IN-5 is a potent and selective inhibitor of MMP-2/MMP-13 (IC50=3.6 μM/14.6 μM), involved in osteoarthritis (OA). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
